Published in Biopolymers on February 03, 2012
Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin. PLoS One (2014) 1.38
The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis. Nat Chem Biol (2014) 0.93
Enhanced Aromatic Sequons Increase Oligosaccharyltransferase Glycosylation Efficiency and Glycan Homogeneity. Chem Biol (2015) 0.81
Mapping N-linked glycosylation of carbohydrate-active enzymes in the secretome of Aspergillus nidulans grown on lignocellulose. Biotechnol Biofuels (2016) 0.75
The Dependence of Carbohydrate-Aromatic Interaction Strengths on the Structure of the Carbohydrate. J Am Chem Soc (2016) 0.75
Alteration of the proteostasis network of plant cells promotes the post-endoplasmic reticulum trafficking of recombinant mutant (L444P) human β-glucocerebrosidase. Plant Signal Behav (2014) 0.75
Stabilizing the CH2 Domain of an Antibody by Engineering in an Enhanced Aromatic Sequon. ACS Chem Biol (2016) 0.75
Interplay between protein glycosylation pathways in Alzheimer's disease. Sci Adv (2017) 0.75
Molecular-scale features that govern the effects of O-glycosylation on a carbohydrate-binding module. Chem Sci (2015) 0.75
Global analysis of protein localization in budding yeast. Nature (2003) 33.22
Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem (1985) 26.05
The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol (1988) 12.87
Intracellular functions of N-linked glycans. Science (2001) 8.39
A revised set of potentials for beta-turn formation in proteins. Protein Sci (1994) 4.97
Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell (1997) 4.24
Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science (1995) 3.62
An evolving view of the eukaryotic oligosaccharyltransferase. Glycobiology (2005) 3.26
Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology (2003) 3.19
The folding mechanism of a beta-sheet: the WW domain. J Mol Biol (2001) 3.00
Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol (2006) 2.88
Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. J Mol Biol (1989) 2.86
Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. Nature (1992) 2.76
The biological and chemical basis for tissue-selective amyloid disease. Cell (2005) 2.76
De novo design and structural characterization of proteins and metalloproteins. Annu Rev Biochem (1999) 2.69
An experimental survey of the transition between two-state and downhill protein folding scenarios. Proc Natl Acad Sci U S A (2008) 2.57
Context-dependent contributions of backbone hydrogen bonding to beta-sheet folding energetics. Nature (2004) 2.44
Glycoprotein structural genomics: solving the glycosylation problem. Structure (2007) 2.40
Recognition of the oligosaccharide and protein moieties of glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. Biochemistry (1992) 2.35
Structure of domain 1 of rat T lymphocyte CD2 antigen. Nature (1991) 2.31
Structure-function-folding relationship in a WW domain. Proc Natl Acad Sci U S A (2006) 2.28
Tuning the free-energy landscape of a WW domain by temperature, mutation, and truncation. Proc Natl Acad Sci U S A (2003) 2.15
Effect of N-linked glycosylation on glycopeptide and glycoprotein structure. Curr Opin Chem Biol (1999) 2.11
Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem Sci (2001) 2.08
N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol (2007) 2.06
Conformational studies of oligosaccharides and glycopeptides: complementarity of NMR, X-ray crystallography, and molecular modelling. Chem Rev (2002) 2.02
Minimal model systems for beta sheet secondary structure in proteins. Curr Opin Chem Biol (1998) 1.99
Effect of glycosylation on protein folding: a close look at thermodynamic stabilization. Proc Natl Acad Sci U S A (2008) 1.97
Conformations of amino acids in proteins. Acta Crystallogr D Biol Crystallogr (2002) 1.95
The COPII cage: unifying principles of vesicle coat assembly. Nat Rev Mol Cell Biol (2006) 1.88
An adaptable standard for protein export from the endoplasmic reticulum. Cell (2007) 1.86
The ER protein folding sensor UDP-glucose glycoprotein-glucosyltransferase modifies substrates distant to local changes in glycoprotein conformation. Nat Struct Mol Biol (2004) 1.78
An automated classification of the structure of protein loops. J Mol Biol (1997) 1.77
WW: An isolated three-stranded antiparallel beta-sheet domain that unfolds and refolds reversibly; evidence for a structured hydrophobic cluster in urea and GdnHCl and a disordered thermal unfolded state. Protein Sci (1999) 1.75
N-linked oligosaccharides as outfitters for glycoprotein folding, form and function. Trends Biochem Sci (2006) 1.71
Influence of the carbohydrate moiety on the stability of glycoproteins. Biochemistry (1996) 1.69
Co-operative interactions during protein folding. J Mol Biol (1992) 1.68
Definition of the lectin-like properties of the molecular chaperone, calreticulin, and demonstration of its copurification with endomannosidase from rat liver Golgi. J Biol Chem (1996) 1.65
Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci (2005) 1.61
Unraveling the mechanism of protein N-glycosylation. J Biol Chem (2004) 1.61
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Exp Hematol (2003) 1.57
The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. Proc Natl Acad Sci U S A (2009) 1.54
Glycoproteins: glycan presentation and protein-fold stability. Structure (1999) 1.51
Engineering a beta-sheet protein toward the folding speed limit. J Phys Chem B (2005) 1.49
Pharmacological significance of glycosylation in therapeutic proteins. Curr Opin Biotechnol (2009) 1.47
Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. Structure (1994) 1.44
Conformational implications of asparagine-linked glycosylation. Proc Natl Acad Sci U S A (1995) 1.40
A window of opportunity: timing protein degradation by trimming of sugars and ubiquitins. Trends Biochem Sci (2005) 1.39
Localized thermodynamic coupling between hydrogen bonding and microenvironment polarity substantially stabilizes proteins. Nat Struct Mol Biol (2009) 1.37
Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs (2010) 1.37
Effects of glycosylation on peptide conformation: a synergistic experimental and computational study. J Am Chem Soc (2004) 1.37
Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. Biochemistry (2008) 1.33
Folding of glycoproteins: toward understanding the biophysics of the glycosylation code. Curr Opin Struct Biol (2009) 1.33
Persistent glycoprotein misfolding activates the glucosidase II/UGT1-driven calnexin cycle to delay aggregation and loss of folding competence. Mol Cell (2005) 1.32
Characterization of the structure and function of W --> F WW domain variants: identification of a natively unfolded protein that folds upon ligand binding. Biochemistry (1999) 1.30
N-linked glycan recognition and processing: the molecular basis of endoplasmic reticulum quality control. Curr Opin Struct Biol (2006) 1.30
The conformational effects of N-glycosylation on the tailpiece from serum IgM. Eur J Biochem (1991) 1.28
Modulation of protein structure and function by asparagine-linked glycosylation. Chem Biol (1996) 1.28
Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns. Science (2011) 1.27
The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin Immunol (2000) 1.27
Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis. Nat Chem Biol (2010) 1.26
Three-dimensional structure of acylphosphatase. Refinement and structure analysis. J Mol Biol (1992) 1.24
NMR solution structure of the isolated Apo Pin1 WW domain: comparison to the x-ray crystal structures of Pin1. Biopolymers (2002) 1.24
The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain. Proc Natl Acad Sci U S A (1993) 1.20
The effect of carbohydrate on the structure and stability of erythropoietin. J Biol Chem (1991) 1.18
A molecular basis for glycosylation-induced conformational switching. Chem Biol (1998) 1.17
The effect of backbone cyclization on the thermodynamics of beta-sheet unfolding: stability optimization of the PIN WW domain. J Am Chem Soc (2002) 1.15
Incorporating beta-turns and a turn mimetic out of context in loop 1 of the WW domain affords cooperatively folded beta-sheets. J Am Chem Soc (2001) 1.14
Conformational influences of glycosylation of a peptide: a possible model for the effect of glycosylation on the rate of protein folding. Proc Natl Acad Sci U S A (1996) 1.10
Minor folding defects trigger local modification of glycoproteins by the ER folding sensor GT. EMBO J (2005) 1.10
Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain. Biochem Biophys Res Commun (2006) 1.09
The endoplasmic reticulum glucosyltransferase recognizes nearly native glycoprotein folding intermediates. J Biol Chem (2004) 1.08
Evaluating beta-turn mimics as beta-sheet folding nucleators. Proc Natl Acad Sci U S A (2009) 1.07
Probing the effect of the outer saccharide residues of N-linked glycans on peptide conformation. J Am Chem Soc (2001) 1.05
The role of the turn in beta-hairpin formation during WW domain folding. Protein Sci (2007) 1.05
Sequence determinants of thermodynamic stability in a WW domain--an all-beta-sheet protein. Protein Sci (2009) 1.00
Perturbing the folding energy landscape of the bacterial immunity protein Im7 by site-specific N-linked glycosylation. Proc Natl Acad Sci U S A (2010) 1.00
Semisynthesis of a glycosylated Im7 analogue for protein folding studies. J Am Chem Soc (2005) 0.97
A cross-strand Trp Trp pair stabilizes the hPin1 WW domain at the expense of function. Protein Sci (2007) 0.97
Structural requirements for additional N-linked carbohydrate on recombinant human erythropoietin. J Biol Chem (2004) 0.96
Analysis of the conserved glycosylation site in the nicotinic acetylcholine receptor: potential roles in complex assembly. Chem Biol (1995) 0.96
N-glycosylation is required for human CD2 immunoadhesion functions. J Biol Chem (1992) 0.95
Novel long-lasting interferon alpha derivatives designed by glycoengineering. Biochimie (2007) 0.94
Context-dependent effects of asparagine glycosylation on Pin WW folding kinetics and thermodynamics. J Am Chem Soc (2010) 0.93
Understanding the mechanism of beta-sheet folding from a chemical and biological perspective. Biopolymers (2008) 0.92
Composition and sequence specific resonance assignments of the heterogeneous N-linked glycan in the 13.6 kDa adhesion domain of human CD2 as determined by NMR on the intact glycoprotein. Biochemistry (1995) 0.92
Intramolecular glycan-protein interactions in glycoproteins. Methods Enzymol (2010) 0.92
Glycosylation of the enhanced aromatic sequon is similarly stabilizing in three distinct reverse turn contexts. Proc Natl Acad Sci U S A (2011) 0.92
1H resonance assignments and secondary structure of the 13.6 kDa glycosylated adhesion domain of human CD2. Biochemistry (1993) 0.90
Influence of hPin1 WW N-terminal domain boundaries on function, protein stability, and folding. Protein Sci (2007) 0.88
Post-translational regulation of expression and conformation of an immunoglobulin domain in yeast surface display. Biotechnol Bioeng (2006) 0.82
Glycosylation of synthetic peptides breaks helices. Phosphorylation results in distorted structure. Int J Pept Protein Res (1991) 0.82
Synthesis of a negatively charged dibenzofuran-based beta-turn mimetic and its incorporation into the WW miniprotein-enhanced solubility without a loss of thermodynamic stability. J Am Chem Soc (2002) 0.82
Synthesis and conformational studies of N-glycosylated analogues of the HIV-1 principal neutralizing determinant. Biochemistry (1992) 0.82
Crystallization and preliminary crystallographic analysis of human common-type acylphosphatase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.81
Chemical glycosylation of peptide T at natural and artificial glycosylation sites stabilizes or rearranges the dominant reverse turn structure. Biochem Biophys Res Commun (1992) 0.80
Glycosylation-modified erythropoietin with improved half-life and biological activity. Int J Hematol (2010) 0.79
Response: CD2: An Exception to the Immunologlobulin Superfamily Concept? Science (1996) 0.77
Adapting proteostasis for disease intervention. Science (2008) 13.22
Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature (2011) 11.07
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A (2004) 7.55
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science (2003) 6.68
Recognition of bacterial glycosphingolipids by natural killer T cells. Nature (2005) 6.38
Opposing activities protect against age-onset proteotoxicity. Science (2006) 5.85
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (2011) 5.44
TRPM8 is required for cold sensation in mice. Neuron (2007) 5.25
Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem (2009) 5.23
Semen-derived amyloid fibrils drastically enhance HIV infection. Cell (2007) 5.23
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell (2006) 5.01
Therapeutic approaches to protein-misfolding diseases. Nature (2003) 4.57
Functional amyloid--from bacteria to humans. Trends Biochem Sci (2007) 4.50
Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med (2007) 4.47
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol (2006) 4.20
Functional amyloid formation within mammalian tissue. PLoS Biol (2006) 3.92
Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol (2005) 3.70
Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science (2005) 3.63
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology (2012) 3.48
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 3.48
Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell (2008) 3.11
Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell (2009) 2.87
CLEC5A is critical for dengue-virus-induced lethal disease. Nature (2008) 2.79
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc Natl Acad Sci U S A (2007) 2.78
The biological and chemical basis for tissue-selective amyloid disease. Cell (2005) 2.76
Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease. Proc Natl Acad Sci U S A (2002) 2.71
Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo. Proc Natl Acad Sci U S A (2006) 2.70
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70
Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science (2003) 2.63
An experimental survey of the transition between two-state and downhill protein folding scenarios. Proc Natl Acad Sci U S A (2008) 2.57
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci U S A (2005) 2.50
Context-dependent contributions of backbone hydrogen bonding to beta-sheet folding energetics. Nature (2004) 2.44
Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci U S A (2009) 2.31
Structure-function-folding relationship in a WW domain. Proc Natl Acad Sci U S A (2006) 2.28
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A (2012) 2.27
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Acc Chem Res (2005) 2.25
Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity. Proc Natl Acad Sci U S A (2002) 2.25
Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants. ACS Chem Biol (2006) 2.25
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med (2005) 2.18
Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl (2004) 2.18
Tuning the free-energy landscape of a WW domain by temperature, mutation, and truncation. Proc Natl Acad Sci U S A (2003) 2.15
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci U S A (2004) 2.14
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A (2005) 2.13
Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proc Natl Acad Sci U S A (2008) 2.09
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry (2004) 2.08
Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Nat Chem Biol (2011) 2.08
Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A (2011) 2.04
Synthesis of sugar arrays in microtiter plate. J Am Chem Soc (2002) 1.96
Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells. Chem Biol (2008) 1.95
HIV-1 protease: mechanism and drug discovery. Org Biomol Chem (2003) 1.90
Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep (2013) 1.87
An adaptable standard for protein export from the endoplasmic reticulum. Cell (2007) 1.86
Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl (2004) 1.86
ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol (2003) 1.82
Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity. Chem Biol (2004) 1.76
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci U S A (2013) 1.73
Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1. Mol Cell (2006) 1.71
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol (2012) 1.70
Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles. Chem Biol (2005) 1.68
Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A (2006) 1.66
Efficient and stereoselective synthesis of α(2→9) oligosialic acids: from monomers to dodecamers. Angew Chem Int Ed Engl (2011) 1.65
Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov (2002) 1.63
Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease. Chem Biol (2006) 1.63
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr Opin Struct Biol (2010) 1.62
Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc Natl Acad Sci U S A (2007) 1.62
Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity. Sci Transl Med (2011) 1.62
Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol (2006) 1.60
A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A (2008) 1.59
Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention. J Med Chem (2007) 1.58
Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes. J Am Chem Soc (2007) 1.56
Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 1.55
Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli. Proc Natl Acad Sci U S A (2009) 1.55
Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des (2008) 1.55
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol (2013) 1.54
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J Med Chem (2004) 1.54
The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. Proc Natl Acad Sci U S A (2009) 1.54